Opening Session BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY Opening Session Opening Session Dr. Felicia Knaul Director, Harvard Global Equity Initiative Associate Professor, Harvard Medical School Felicia Knaul, MA, PhD (Economics, Harvard University) is the newly- appointed director of the Harvard Global Equity Initiative and Associate Professor at the Harvard Medical School. She is also a Senior Associate with the Mexican Health Foundation, where she has collaborated with since 1994. As a result of her personal experience, she founded Cáncer de Mama: Tómatelo a Pecho (Breast Cancer: Take it to Heart) in 2007, a program that undertakes and promotes research, advocacy, awareness and early detection initiatives on breast cancer in Latin America. Her book on her life with breast cancer “Tómatelo a Pecho” was released in October. Dr. Knaul has more than 100 publications and is a member of numerous organizations, including: Consultative Council of UNICEF in Mexico; Harvard-Mexico Foundation, Mexican Council on Competitiveness; and the High Level Early Childhood Development Secretariat at the Earth Institute of Columbia University. Dr. Knaul has held senior government posts at the Ministries of Education and Social Development in Mexico and at the Department of Planning of Colombia. She has worked for the WHO, World Bank, the Inter-American Development Bank and UNICEF. Dr. Knaul is Canadian, and resides in Boston and Mexico City. She and her husband, Dr. Julio Frenk, have two children, Hannah and Mariana Havivah. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 2 Opening Session Dr. Jeffrey Flier Dean, Faculty of Medicine of the Harvard Medical School Jeffrey S. Flier was named dean of the Faculty of Medicine at Harvard University in 2007. An authority on the molecular causes of obesity and diabetes, Dean Flier is also the Carolyn Shields Walker professor of medicine at Harvard Medical School. Previously he served as the HMS faculty dean for academic programs and chief academic officer for Beth Israel Deaconess Medical Center. Dean Flier received a BS from City College of New York in 1968 and an MD from Mount Sinai School of Medicine in 1972, graduating with the Elster Award for Highest Academic Standing. Following his residency training in internal medicine at Mount Sinai Hospital, he joined the National Institutes of Health. In 1978, he joined the Faculty of medicine at HMS and was named chief of the Diabetes Unit at Beth Israel Hospital until 1990, when he became chief of the Endocrine Division. Dean Flier has authored more than 200 scholarly papers and reviews. He is a fellow of the Institute of Medicine of the National Academy of Sciences, the American Association for the Advancement of Science and the American Academy of Arts and Sciences. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 3 Opening Session Dr. Margaret Chan Director-General, World Health Organization (WHO) Dr. Margaret Chan, from the People’s Republic of China, obtained her medical degree from the University of Western Ontario in Canada. She joined the Hong Kong Department of Health in 1978, where her career in public health began. In 1994, Dr. Chan was appointed Director of Health of Hong Kong. In her nine-year tenure as director, she launched new services to prevent the spread of disease and promote better health. She also introduced new initiatives to improve communicable disease surveillance and response, enhance training for public health professionals, and establish better local and international collaboration. She effectively managed outbreaks of avian influenza and of severe acute respiratory syndrome. In 2003, Dr. Chan joined WHO as Director of the Department for Protection of the Human Environment. In June 2005, she was appointed Director, Communicable Diseases Surveillance and Response as well as Representative of the Director- General for Pandemic Influenza. In September 2005, she was named Assistant Director-General for Communicable Diseases. Dr. Chan was appointed to the post of Director-General on November 9, 2006. Her term will run through June 2012. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 4 Opening Session Her Excellency, Madam Tobeka Madiba Zuma First Lady, The Republic of South Africa Vice Chairperson, Forum of African First Ladies Against Breast & Cervical Cancer Her Excellency Madame Tobeka Stacie Madiba-Zuma, First Lady KaMadiba of the Republic of South Africa, is a humanitarian activist and Vice Chairperson for Forum of African First Ladies Against Breast & Cervical Cancer. Madame Madiba-Zuma began her career in banking, development finance and cellular technology. As a leader in finance, she launched initiatives empowering young women and meeting community needs through various successful communication campaigns. In her current role as Vice Chairperson for the Forum of African First Ladies Against Breast & Cervical Cancer she focuses her efforts in communication about cancer research and prevention. She has traveled extensively through Africa and globally as an ambassador for prevention and screening campaigns addressing cervical cancer and breast cancer. As First Lady she has also focused her humanitarian efforts on the overall wellbeing of veterans and women, particularly the elderly, children and mothers. In addition to her work as a public spokesperson, she continues to assist orphaned children, particularly those living with HIV/AIDS, through meaningful public private partnerships. Madame Madiba-Zuma is the mother of five children and lives in Durban. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 5 Opening Session Dr. Lawrence N. Shulman Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute Lawrence N. Shulman, M.D., is Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology at Dana-Farber Cancer Institute. He focuses his efforts on the clinical services for both adult and pediatric care at the Dana-Farber Cancer Institute (DFCI) and its partners, Brigham and Women’s Hospital, and Children’s Hospital. Dr. Shulman has served as one of the component leaders through the DFCI strategic planning initiative. He is Director of Network Development for Dana-Farber/Brigham and Women’s Cancer Center, and oversees DFCI ambulatory oncology units at several regional hospitals. He is also physician leader for the development of clinical information systems for DFCI. He is a member of American Society of Clinical Oncology’s (ASCO) Quality of Care Committee and ASCO’s Electronic Health Record Workgroup. He is a member of the Commission on Cancer of the American College of Surgeons. A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies. He is the national principal investigator on a North American Breast Intergroup Phase III Adjuvant trial, and is the Global Principal Investigator on a Phase III vaccine trial for patients with metastatic breast cancer. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 6 Opening Session Her Royal Highness Princess Dina Mired Director-General, King Hussein Cancer Foundation; Honorary Chairperson, Jordan Breast Cancer Program, Hashemite Kingdom of Jordan As the mother of a cancer survivor, Princess Dina is passionate in her efforts to combat cancer. Since 2003, she has led the King Hussein Cancer Foundation (KHCF) as Director General. In this capacity, she founded and developed the Fundraising and Development Department of the Foundation, making it one of the best fundraising institutions in Jordan and the region. Today KHCF is the largest source of non-profit funds dedicated to combating cancer in Jordan. Under her direct leadership, KHCF has succeeded in unifying and enlisting all segments of society in the fight against cancer. Princess Dina has also restructured and expanded KHCF’s Healthcare Program for cancer coverage, making it the only non-profit cancer coverage program in Jordan that also offers early detection services. Princess Dina is the Honorary Chairperson of Jordan's National Breast Cancer Program. She is also the Honorary Member of the Mediterranean Task Force for Cancer Control in Italy and a LIVESTRONG Global Envoy for the Lance Armstrong Foundation. KHCF is an independent non-governmental, not-for-profit institution to combat cancer in Jordan, and the Middle East region. KHCF is the legal umbrella organization responsible for the King Hussein Cancer Center, the Foundation’s medical arm. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY 7 Opening Session Dr. Drew Gilpin Faust President, Harvard University Drew Gilpin Faust took office as Harvard University’s 28th president on July 1, 2007. A historian of the U.S. Civil War and the American South, Dr. Faust is also the Lincoln Professor of History in the Faculty of Arts and Sciences. She previously served as founding dean of the Radcliffe Institute for Advanced Study (2001-2007). Before coming to Radcliffe, Dr. Faust was the Annenberg Professor of History and director of the Women’s Studies Program at the University of Pennsylvania.